MVision AI
News and Articles

Keep up to date with our latest articles

Hot Topics 🔥

Press Room

11.8.2022

Cancer in Ireland – Raising Survival Rates

Every year, almost 45.000 people in Ireland are diagnosed with cancer, making Ireland the country with the highest cancer incidence in Europe. The 5 most diagnosed types of cancer in Ireland are: Skin cancer Prostate cancer Breast cancer Bowel cancer Lung cancer 1 out of 4 deaths in Ireland can…

Articles

3.8.2022

MVision’s GBS™ is Featured in 5 Posters at the German Society of Radiation Oncology (DEGRO) Annual Meeting

This week, we're focusing on high-impact research presented during the German Society of Radiation Oncology (DEGRO) Annual Meeting. Five posters included a focus on MVision’s guideline-based segmentation, GBS™, solution (also available as an on-premise solution).   Development of an AI-based auto-contouring of upper and lower jaw segments for optimized radiation planning…

News

29.7.2022

Improving Tools to Fight Glioblastoma

 Background Glioblastoma multiforme represents approximately half of the cases of central nervous system malignant tumors. The median age at diagnosis is 64 years, and the incidence was reported to be approximately 3 cases in 100 000 people. Genetic conditions, such as Li Fraumeni and Lynch Syndrome,  are associated with a…

Articles

17.6.2022

RT for Prostate Cancer: Faster and Better – Is it Possible?

Background Worldwide, more than 1 400 000 men were diagnosed with prostate cancer in 2020, and it is estimated that one third will need radiotherapy during their treatment. (more…)

Articles

31.5.2022

MVision AI Receives FDA 510(k) Clearance for Guideline-Based Segmentation Radiotherapy Software

Helsinki, 31st of May, 2022 - MVision AI announces that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guideline-based, AI-powered software for automatic segmentation for radiotherapy. (more…)

News, Press Releases

24.3.2022

Outcomes of SABR for Colorectal Cancer

Colorectal cancer (CRC) is one of the most common types of cancer diagnosed in the UK. About 41,000 people get cancer in the large bowel each year in the UK. In 2020, the WHO reported that colorectal cancer accounted for 10% of the cancers diagnosed annually. (Global Cancer Observatory) This…

Articles

18.3.2022

Indications and Effects of SABR for Renal Cancer

Renal cell carcinoma (RCC), generally referred to as Kidney Cancer, is among the ten most common cancers for men and women. The lifetime risk for developing RCC in men is about 1 in 46 and 1 in 80 for women. The American Cancer Society estimates about 79,000 new diagnoses and…

News

24.2.2022

What is Supervised and Unsupervised Machine Learning?

Machine learning has become vital to the modern world, turning data into real, actionable insights. In radiotherapy, there has been a continuous increase in patient-specific needs met with the help of artificial intelligence, from quality personalized treatment to medical imaging.  In the machine learning field, there are two main types…

News

10.2.2022

New Year, New Patient Backlog: RT in the UK

In 2021, reports showed that cancer patients wait up to 62 days for the first dose of radiotherapy treatment in the UK. The numbers of cancer patients facing these delays have hit record highs over the last year. Just last month, NHS Wales reported that numbers on waiting lists for…

Articles

19.1.2022

MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki - 19th of January, 2022 - MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development…

News, Press Releases

7.1.2022

What guidelines do clinicians follow for breast contouring?

According to the NHS, breast cancer is the most common type of cancer in the UK. Roughly 1 in 8 women are diagnosed with breast cancer during their lifetime. However, there is a good chance of recovery if the cancer is detected early. (NHS) The World Health Organization estimates that…

News

29.12.2021

2021 MVision AI Re-cap: The Year of GCAIS™

2021 is an innovative and  foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…

News

Testimonials

Hear what people say about us.

Customer Portfolio